KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $6.9 million.

  • Medpace Holdings' Depreciation and Depletion fell 320.5% to $6.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.2 million, marking a year-over-year decrease of 218.64%. This contributed to the annual value of $27.2 million for FY2025, which is 218.64% down from last year.
  • Latest data reveals that Medpace Holdings reported Depreciation and Depletion of $6.9 million as of Q4 2025, which was down 320.5% from $6.8 million recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' Depreciation and Depletion peaked at $7.2 million during Q3 2024, and registered a low of $3.8 million during Q1 2021.
  • Over the past 5 years, Medpace Holdings' median Depreciation and Depletion value was $6.1 million (recorded in 2023), while the average stood at $5.7 million.
  • As far as peak fluctuations go, Medpace Holdings' Depreciation and Depletion skyrocketed by 5540.15% in 2021, and later crashed by 481.98% in 2025.
  • Medpace Holdings' Depreciation and Depletion (Quarter) stood at $4.2 million in 2021, then grew by 21.17% to $5.1 million in 2022, then increased by 26.62% to $6.4 million in 2023, then grew by 11.26% to $7.1 million in 2024, then dropped by 3.21% to $6.9 million in 2025.
  • Its Depreciation and Depletion stands at $6.9 million for Q4 2025, versus $6.8 million for Q3 2025 and $6.8 million for Q2 2025.